Spinal implants pass 24-Month safety check in 77 patients
NCT ID NCT04670536
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 77 adults who received spinal implants (PASS LP, PASS DEGEN, or PASS TULIP PRIME) to treat degenerative spine conditions like disc degeneration or spinal deformity. The main goal was to see if the bones fused properly after 24 months. Researchers also tracked pain and quality of life changes. The study is already completed and supports the implants' safety and effectiveness for medium-term use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PASS LP, PASS DEGEN, and PASS TULIP PRIME spinal implants
What this could lead to
If successful, this could confirm that these implants are safe and effective for fusing spine bones in people with degenerative spine disease.
What could go wrong
This is a small, completed post-market study with no control group, so results may not apply to everyone. Fusion may fail or complications could occur.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL DEFORMITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU Tours, Hôpital de Bretonneau
Tours, 37044, France
-
Clinique des Cèdres
Cornebarrieu, 31700, France
-
Clinique du Dos Bordeaux - Terrefort
Bruges, 33520, France
-
Hôpital Pitié-Salpêtrière AP-HP
Paris, Île-de-France Region, 75651, France